No screening tests are indicated as the disease is sufficiently unusual for the pick up rate on routine abdominal scanning being so low as to not be feasible on health economics. There is one exception and that is the Von Hippel Lindau group of patients, who are sufficiently at high enough risk to warrant such screening by abdominal scanning.
